Endostatin, an antiangiogenic drug, induces tumor stabilization after chemotherapy or anti-CD20 therapy in a NOD/SCID mouse model of human high-grade non-Hodgkin lymphoma (Q73984305)
Jump to navigation
Jump to search
scientific article published on 01 July 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Endostatin, an antiangiogenic drug, induces tumor stabilization after chemotherapy or anti-CD20 therapy in a NOD/SCID mouse model of human high-grade non-Hodgkin lymphoma |
scientific article published on 01 July 2000 |
Statements
Endostatin, an antiangiogenic drug, induces tumor stabilization after chemotherapy or anti-CD20 therapy in a NOD/SCID mouse model of human high-grade non-Hodgkin lymphoma (English)
Bertolini F
Fusetti L
Mancuso P
Gobbi A
Corsini C
Martinelli G